Boston Scientific Corporation (BSX) Financial Statements (2026 and earlier)

Company Profile

Business Address 300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,9654148659281,9251,734
Cash and cash equivalent1,9654148659281,9251,734
Short-term investments      
Restricted cash and investments80     
Receivables2,9262,5582,2281,9701,7781,531
Inventory, net of allowances, customer advances and progress billings2,9432,8102,4841,8671,6101,351
Inventory2,9432,8102,4841,8671,6101,351
Prepaid expense299307315264205194
Disposal group, including discontinued operation      1,133
Other current assets  831621   
Other undisclosed current assets581 1731799751
Total current assets:8,7946,9206,5145,7606,3176,694
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 4,0363,2942,8592,4462,2522,084
Intangible asset, including goodwill, after accumulated amortization25,30123,77320,39018,82218,10915,868
Goodwill18,28217,08914,38712,92011,9889,951
Intangible asset, excluding goodwill, after accumulated amortization7,0196,6846,0035,9026,1215,917
Deferred income tax assets3,6753,6553,8413,9424,1424,210
Other noncurrent assets1,8661,7541,5311,5001,4101,921
Other undisclosed noncurrent assets1(1)1(1)(1) 
Total noncurrent assets:34,87932,47528,62226,70925,91224,083
TOTAL ASSETS:43,67339,39535,13632,46932,22930,777
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,3453,7333,5883,0223,2302,710
Accounts payable1,144960942862794513
Accrued liabilities3,2012,7732,6462,1602,4362,197
Debt2991,7785312026113
Other liabilities795887814761783958
Other undisclosed current liabilities  1    
Total current liabilities:5,4396,3994,9333,8034,2743,681
Noncurrent Liabilities
Long-term debt and lease obligation, including:11,1378,9688,5718,9158,8049,130
Finance lease, liability 122     
Other undisclosed long-term debt and lease obligation11,0158,9688,5718,9158,8049,130
Liabilities, other than long-term debt2,6252,0252,1012,1792,5302,639
Deferred income tax liabilities220155134144310330
Other liabilities2,4051,8701,9672,0352,2202,309
Other undisclosed noncurrent liabilities   1(1)(1)1
Total noncurrent liabilities:13,76210,99310,67311,09311,33311,770
Total liabilities:19,20117,39215,60614,89615,60715,451
Equity
Equity, attributable to parent, including:24,23321,77019,28217,57416,36015,120
Common stock171717171717
Treasury stock, value(2,251)(2,251)(2,251)(2,251)(2,251)(2,251)
Additional paid in capital21,50521,05620,64720,28919,98619,732
Accumulated other comprehensive income (loss)(610)27549269  
Retained earnings (accumulated deficit)5,5712,673819(750)(1,392)(2,378)
Other undisclosed equity, attributable to parent 1 1   
Equity, attributable to noncontrolling interest239233248   
Other undisclosed equity    (1)262206
Total equity:24,47222,00319,53017,57316,62215,326
TOTAL LIABILITIES AND EQUITY:43,67339,39535,13632,46932,22930,777

Income Statement (P&L) ($ in millions)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues20,07416,74714,24012,68211,8889,913
Cost of revenue
(Cost of Product and Service Sold)
(6,221)(5,257)(4,345)(3,956)(3,711)(3,465)
Other undisclosed gross profit1 11  
Gross profit:13,85411,4909,8968,7278,1776,448
Operating expenses(10,241)(8,887)(7,553)(7,078)(6,978)(6,528)
Operating income (loss):3,6132,6032,3431,6491,199(80)
Nonoperating income (expense)(228)(321)(152)(508)(123)1
Investment income, nonoperating   (59)(23)328398
Other nonoperating income (expense)(228)(321)(93)(38)218362
Interest and debt expense   (265)(470)(341)(361)
Income (loss) from continuing operations before equity method investments, income taxes:3,3852,2821,926671735(440)
Other undisclosed income from continuing operations before income taxes  59470341361
Income (loss) from continuing operations before income taxes:3,3852,2821,9851,1411,076(79)
Income tax expense(493)(436)(393)(443)(36)(2)
Income (loss) from continuing operations:2,8921,8461,5926981,040(81)
Income (loss) before gain (loss) on sale of properties:1,040(81)
Other undisclosed net income (loss)     1(1)
Net income (loss):2,8921,8461,5926981,041(82)
Net income attributable to noncontrolling interest68    
Net income (loss) attributable to parent:2,8981,8541,5926981,041(82)
Other undisclosed net loss available to common stockholders, basic  (1)(22)(56)(56)(33)
Net income (loss) available to common stockholders, diluted:2,8981,8531,570642985(115)

Comprehensive Income ($ in millions)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):2,8921,8461,5926981,041(82)
Other comprehensive income (loss)(872)218(230)656(63)
Other undisclosed comprehensive loss     (1) 
Comprehensive income (loss):2,0202,0641,3627041,096(145)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(6)1511   
Other undisclosed comprehensive loss, net of tax, attributable to parent(1)     
Comprehensive income (loss), net of tax, attributable to parent:2,0132,0791,3737041,096(145)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: